Open AccessCefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: a randomized study
Author(s) -
Michael Samarinas,
Konstantinos Skriapas,
Iraklis Mitsogiannis,
Stavros Gravas,
Anastasios Karatzas,
Vassilios Tzortzis
Publication year - 2020
Publication title -
central european journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.403
H-Index - 20
eISSN - 2080-4873
pISSN - 2080-4806
DOI - 10.5173/ceju.2020.0072
Subject(s) - cefixime , medicine , prostate biopsy , urology , biopsy , urinary system , gastroenterology , surgery , antibiotics , prostate , cephalosporin , microbiology and biotechnology , biology , cancer
Urinary tract infections may be a severe complication after prostate biopsy. The aim of our study is to investigate the efficacy of cefixime versus prulifloxacin, as a prophylactic treatment in the era of fluoroquinolone resistance.